American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 8-10 , July 2007

Subclinical Vascular Disease of the Brain in Dialysis Patients

  • Stephen L. Seliger, MD, MS

      Affiliations

    • University of Maryland School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationAddress correspondence to Stephen L. Seliger, MD, MS, Division of Nephrology, University of Maryland School of Medicine, 22 S. Greene St, N3W143, Baltimore, MD 21201.
    • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Tufts-New England Medical Center, Boston, Massachusetts

References 

  1. Seliger SL, Gillen DL, Longstreth WT, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603–609
  2. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820–826
  3. Stefanidis I, Bach R, Mertens PR, et al. Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery. Clin Nephrol. 2005;64:129–137
  4. Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis. 2005;45:1058–1066
  5. Vermeer SE, den Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34:392–396
  6. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–1222
  7. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology. 2001;57:1222–1229
  8. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126–1129
  9. Seliger SL, Longstreth WT, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16:3721–3727
  10. Nakatani T, Naganuma T, Uchida J, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86–90
  11. Naganuma T, Uchida J, Tsuchida K, et al. Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int. 2005;67:2434–2439
  12. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391–1398
  13. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report (A review). Stroke. 1995;26:1293–1301
  14. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke (The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy). Circulation. 2005;112:1644–1650
  15. Kuller LH, Longstreth WT, Arnold AM, et al. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–1825
  16. Longstreth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people (The Cardiovascular Health Study). Stroke. 1996;27:1274–1282
  17. Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging (The Rotterdam Study). Stroke. 1994;25:1109–1115
  18. Schmidt R, Fazekas F, Offenbacher H, et al. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology. 1993;43:2490–2494
  19. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246–253
  20. Ylikoski R, Ylikoski A, Erkinjuntti T, et al. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol. 1993;50:818–824
  21. Fazekas G, Fazekas F, Schmidt R, et al. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci. 1995;134:83–88
  22. Martinez-Vea A, Salvadó E, Bardají A, et al. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis. 2006;47:241–250
  23. Kim C-D, Lee H-J, Kim D-J, et al. High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis. 2007;50:98–107
  24. Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–223
  25. van Straaten ECW, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke. 2006;37:836–840
  26. O’Sullivan M, Summers PE, Jones DK, et al. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology. 2001;57:2307–2310

PII: S0272-6386(07)00792-5

doi: 10.1053/j.ajkd.2007.04.022

American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 8-10 , July 2007

Article Tools